Skip to main content
Galapagos NV logo

Galapagos NV — Investor Relations & Filings

Ticker · GLPG ISIN · BE0003818359 LEI · 549300QKJ78IY0IOV655 BR Manufacturing
Open in API
Filings indexed 2,862 across all filing types
Latest filing 2020-01-13 Regulatory Filings
Country BE Belgium
Listing BR GLPG

About Galapagos NV

https://www.glpg.com/

Galapagos NV is a biotechnology company focused on transforming patient outcomes through scientific innovation. The company is strategically concentrating its efforts on its cell therapy platform, which is engineered for the scalable, decentralized, and rapid production of next-generation treatments. A key feature of this platform is a median 7-day vein-to-vein delivery time. In parallel with this focus, Galapagos is actively seeking partners to take over its portfolio of small molecule assets, including its TYK2 inhibitor program for autoimmune indications. This strategic shift allows the company to prioritize the growth and development of its cell therapy pipeline through internal discovery, partnerships, and acquisitions.

Recent filings

Filing Released Lang Actions
Galapagos completes recruitment of PINTA trial in idiopathic pulmonary fibrosis
Regulatory Filings Classification · 95% confidence The document is a press release dated January 13, 2020, announcing that Galapagos has completed recruitment for its PINTA Phase 2 clinical trial for GLPG1205 in idiopathic pulmonary fibrosis (IPF). It details the trial status, the drug candidate, and provides background information on IPF and the company. This type of announcement, focusing on clinical trial milestones (like recruitment completion) and providing key scientific/business updates outside of mandated periodic financial reports (like 10-K or IR), is characteristic of an Investor Presentation (IP) or a general press release detailing operational progress. Since it is a detailed update on strategy and pipeline progress aimed at investors, Investor Presentation (IP) is the most fitting category, although it is structured as a press release. It is not a formal regulatory filing like 10-K, nor is it a short announcement of a report (RPA/RNS).
2020-01-13 English
6-K Filing
Regulatory Filings
2020-01-13 English
Galapagos to present at 38th Annual J.P. Morgan Healthcare Conference
AGM Information Classification · 95% confidence The document is a press release announcing that Galapagos will present at the '38th Annual J.P. Morgan Healthcare Conference' on specific dates in January 2020. It details the presenter (COO & CFO) and provides a link to the webcast. This type of announcement, which publicizes participation in an industry conference or investor event, is best classified as an Investor Presentation (IP) announcement or related material, as it is designed to communicate company updates to investors in that forum. However, since the document itself is the *announcement* of participation and provides webcast details, and not the presentation slides or the transcript of the presentation itself, it fits the pattern of an announcement regarding investor communication. Given the options, 'Investor Presentation (IP)' is the closest fit for content related to a major healthcare conference presentation, even though it's the announcement rather than the presentation itself. If the document were just a short notice stating 'Presentation materials are available,' it would be RPA. Since it details the event and provides webcast access, IP is the most relevant category for the subject matter.
2020-01-10 English
Gilead holds 25.84% of Galapagos shares
Major Shareholding Notification Classification · 99% confidence The document explicitly states that Galapagos NV received a 'transparency notification' from Gilead Sciences, Inc. regarding changes in shareholding that crossed the 25% threshold. This type of notification, detailing changes in significant share ownership by an investor, directly corresponds to the definition of a Major Shareholding Notification. The text mentions specific dates, share counts, and the crossing of a legal threshold (25%), which are hallmarks of this filing type. It is not an earnings release, annual report, or a general regulatory filing, but a specific disclosure about ownership change.
2020-01-10 English
6-K Filing
Regulatory Filings
2020-01-10 English
6-K Filing
Regulatory Filings
2020-01-10 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.